Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1989Journal of Biological ChemistryOpen Access

5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLewis A. ChodoshCancer Research InstituteAFAndrew FireStanford UniversityMSMark SamuelsZhejiang Chinese Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chodosh et al. (1989) studied this question.

synapsesocial.com/papers/6a6ad0bc01245da06ecb4da9https://doi.org/10.1016/s0021-9258(18)94169-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interactions between RNA polymerase II, factors, and template leading to accurate transcription.1984 · 242 citations
  2. 2DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.1980 · 1,281 citations
  3. 35,6-Dichloro-1-β-D-Ribofuranosylbenzimidazole Inhibits Initiation of Nuclear Heterogeneous RNA Chains in HeLa Cells1976 · 105 citations
  4. 4Separation and characterization of factors mediating accurate transcription by RNA polymerase II.1982 · 304 citations
  5. 5Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription.1986 · 294 citations